Cellular Models of Alpha-Synuclein Aggregation: What Have We Learned and Implications for Future Study
Open Access
- 20 October 2022
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 10 (10) , 2649
Abstract
Alpha-synuclein’s role in diseases termed “synucleinopathies”, including Parkinson’s disease, has been well-documented. However, after over 25 years of research, we still do not fully understand the alpha-synuclein protein and its role in disease. In vitro cellular models are some of the most powerful tools that researchers have at their disposal to understand protein function. Advantages include good control over experimental conditions, the possibility for high throughput, and fewer ethical issues when compared to animal models or the attainment of human samples. On the flip side, their major disadvantages are their questionable relevance and lack of a “whole-brain” environment when it comes to modeling human diseases, such as is the case of neurodegenerative disorders. Although now, with the advent of pluripotent stem cells and the ability to create minibrains in a dish, this is changing. With this review, we aim to wade through the recent alpha-synuclein literature to discuss how different cell culture setups (immortalized cell lines, primary neurons, human induced pluripotent stem cells (hiPSCs), blood–brain barrier models, and brain organoids) can help us understand aggregation pathology in Parkinson’s and other synucleinopathies.Keywords
Funding Information
- Orion Foundation
- Paivikki and Sakari Sohlberg Foundation
- Finnish Parkinson Foundation
- Sigrid Juselius Foundation
- Janne and Aatos Erkko Foundation
This publication has 197 references indexed in Scilit:
- Prion-like spreading of pathological α-synuclein in brainBrain, 2013
- Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in miceJournal of Experimental Medicine, 2012
- Heat‐shock protein 70 modulates toxic extracellular α‐synuclein oligomers and rescues trans‐synaptic toxicityThe FASEB Journal, 2010
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cellsProceedings of the National Academy of Sciences, 2009
- Interplay of α-synuclein binding and conformational switching probed by single-molecule fluorescenceProceedings of the National Academy of Sciences, 2009
- Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signalingNature Biotechnology, 2009
- Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitroVirology, 2008
- α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998